Koninklijke Philips NV vs Solstice Advanced Materials Inc. Common Stock — how do they compare? Koninklijke Philips NV trades at $25.55 (market cap $24.60B), while Solstice Advanced Materials Inc. Common Stock trades at $58.54 (market cap $9.55B). The key difference: Koninklijke Philips NV is far larger — about 2.6× Solstice Advanced Materials Inc. Common Stock's market cap, and Koninklijke Philips NV pays the higher dividend (4.05%). Which is the better fit depends on your goals — on Pluang, investors hold Koninklijke Philips NV for 84 Days and Solstice Advanced Materials Inc. Common Stock for 0 Days on average.
| PHG | SOLS | |
|---|---|---|
Market Cap | $24.60B | $9.55B |
Volume | 1,105,836 | 2,661,277 |
Sector | Health | Basic Materials |
52-Week High | $32.91 | $88.60 |
52-Week Low | $23.81 | $41.43 |
Typical Hold Time | 84 Days | 0 Days |
Enterprise Value | $30.96B | $11.23B |
Dividend Yield | 4.05% | 0.5% |
Signals from Pluang's Aura AI — not financial advice
PHG trades at $24.89, up 0.61% on the day, with a bullish technical signal despite mixed momentum indicators. Recent quarterly earnings have consistently beaten expectations, with Q2 2026 EPS of $0.57 surpassing the $0.40 forecast. Revenue for 2025 was $17.83 billion, with a net income margin of 5.01%, marking a significant recovery from prior losses. Positive news includes new product launches and a $33.7 million ARPA-H award for AI-enabled stroke care, enhancing growth prospects in health technology.
The outlook is cautiously optimistic, supported by earnings momentum and strategic innovations, but risks include high debt levels and competitive pressures. Analyst consensus is Hold-dominated, with 63.64% recommending Hold, indicating tempered expectations amid operational improvements and macroeconomic uncertainties.
Solstice Advanced Materials (SOLS) trades at $60.91, up 0.33% with neutral technical signals. The company shows strong profitability with 30.64% gross margins and 14.95% ROE, though Q4 2025 earnings missed expectations. Recent developments include a $49M R&D expansion and termination of the Element Solutions merger, with the board authorizing a $500M share repurchase program. Analyst consensus is bullish with 80% buy ratings and a $80.22 price target representing 32% upside potential.
SOLS presents a compelling growth story with consistent earnings beats and institutional accumulation, though elevated P/E of 46.07 warrants caution. Key risks include execution challenges post-merger termination and margin pressure as profit margins declined from 6.09% to 5.12% year-over-year. The stock offers substantial upside if management delivers on growth initiatives while maintaining current profitability levels.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →Solstice Advanced Materials Inc. is a specialty materials company spun off from Honeywell in 2025, producing low-global-warming-potential refrigerants, blowing agents, and industrial solvents through its Refrigerants and Applied Solutions segment. Its Electronic and Specialty Materials segment supplies semiconductor materials, high-strength fibers, and healthcare-packaging films.
Read more on SOLS →